A note of thanks from Sandra C. Raymond, President and CEO, Lupus Foundation of America .
Fabulupus is the latest book to receive the Lupus Foundation of America seal of approval. We spoke to the authors to find out more about their motivations for writing the book. Read more!
Anita Roach, Research Program Manager, reports on new lupus therapies and environmental aspects of lupus from American College of Rheumatology's Annual Scientific Meeting last week in San Francisco.
Anifrolumab significantly reduced disease activity as measured by several SLE composite endpoints and improved symptoms of lupus.
With the last day of the American College of Rheumatology Annual Meeting upon us, we’re ready to bring you updates on the latest findings in lupus research.
We’re back for day two of the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco.
10th Anniversary of the Evelyn V. Hess Award Celebrates Past Honorees
Our team is on the ground in San Francisco to bring you the latest in lupus research and live updates from the American College of Rheumatology's Annual Meeting.